Skip to main content
Clinical Trials/NCT04749381
NCT04749381
Unknown
Phase 2

The Role of Traditional Chinese Medicine on Enhanced Recovery After Surgery for Patients With Rectal Cancer Undergoing Curative Surgery: A Randomized Controlled Trial

Peking University Cancer Hospital & Institute1 site in 1 country264 target enrollmentSeptember 28, 2020
ConditionsRectal Cancer

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Rectal Cancer
Sponsor
Peking University Cancer Hospital & Institute
Enrollment
264
Locations
1
Primary Endpoint
Postoperative complications
Last Updated
5 years ago

Overview

Brief Summary

This study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients.

Detailed Description

The hypothesis is that TCM can decrease the postoperative complications for rectal cancer. So the study is to investigate the role of traditional Chinese medicine (TCM) on the postoperative recovery of rectal cancer patients. Patients enrolled in this study will be randomized into two groups with TCM intervention or placebo. The intervention will be described below. Primary endpoint is postoperative complications.

Registry
clinicaltrials.gov
Start Date
September 28, 2020
End Date
February 20, 2023
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Peking University Cancer Hospital & Institute
Responsible Party
Principal Investigator
Principal Investigator

Aiwen Wu

M.D. PH.D. Chief, Unit III & Ostomy Service, Gastrointestinal Cancer Center, Peking University Cancer Hospital & Institute

Peking University Cancer Hospital & Institute

Eligibility Criteria

Inclusion Criteria

  • Signed written consent form;
  • Age from 18 to 75 years old;
  • Pathological diagnosis as rectal adenocarcinoma;
  • undergo laparoscopic curative surgery;
  • Patients' TCM syndrome accords with thoses of spleen deficiency syndrome;

Exclusion Criteria

  • Patients undergo non-curative surgeries;
  • Participants with skin allergy, skin ulceration and diabetes mellitus with poor glycemic control;
  • Participants with severe dysfunction of heart, liver and kidney, who could not receive TCM treatment;
  • Women who are pregnant or breastfeeding;
  • Participants have mental illness or have difficulty in language communication and are unable to complete the study;
  • Participants could not cooperate with this researcher for other reasons.

Outcomes

Primary Outcomes

Postoperative complications

Time Frame: from operation to 30 days after operation

Rates of the complications after curative surgery

Secondary Outcomes

  • recovery of urinary function(from removal of urinary catheter to 30 days after operation)
  • Recovery of fart and bowel function(7 days after operation)
  • The European Organization of Quality of Life Questionnaire-colorectal-29(30 days after operation)
  • Changes of TCM symptoms(30 days after operation)
  • Length of hospital stay(30 days after operation)

Study Sites (1)

Loading locations...

Similar Trials